ACBYX
Price
$15.02
Change
+$0.05 (+0.33%)
Updated
Jan 17 closing price
Net Assets
109.68M
CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
240.18B
Ad is loading...

ACBYX vs CLBCX

Header iconACBYX vs CLBCX Comparison
Open Charts ACBYX vs CLBCXBanner chart's image
American Beacon Balanced Y
Price$15.02
Change+$0.05 (+0.33%)
VolumeN/A
Net Assets109.68M
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets240.18B
ACBYX vs CLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACBYX vs. CLBCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACBYX is a Hold and CLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 240B vs. ACBYX (110M). ACBYX pays higher dividends than CLBCX: ACBYX (1.63) vs CLBCX (1.52). ACBYX was incepted earlier than CLBCX: ACBYX (15 years) vs CLBCX (23 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. ACBYX (48.00). CLBCX has a lower initial minimum investment than ACBYX: CLBCX (250) vs ACBYX (100000). CLBCX annual gain was more profitable for investors over the last year : 11.42 vs. ACBYX (6.61). CLBCX return over 5 years is better than : 26.62 vs. ACBYX (2.10).
ACBYXCLBCXACBYX / CLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years23 years-
Gain YTD2.0381.894108%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets110M240B0%
Annual Yield % from dividends1.631.52107%
Returns for 1 year6.6111.4258%
Returns for 3 years-1.5811.24-14%
Returns for 5 years2.1026.628%
Returns for 10 years6.0556.7811%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin